Share-based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| 2019 Incentive Award Plan |
|
| Share-based Compensation |
|
| Schedule of stock option activity |
| | | | | | | | | | | Weighted | | | | | | Average | | | | Number of | | Exercise | | | | Shares | | Price | | Outstanding, January 1, 2026 | | 47,955 | | $ | 720.00 | | Options granted | | — | | | — | | Options forfeited | | — | | | — | | Outstanding, June 30, 2026 | | 47,955 | | $ | 720.00 | | Exercisable, June 30, 2026 | | 47,516 | | $ | 720.00 | |
|
| Summary of restricted stock units activity |
| | | | | | | | | | | Weighted | | | | | | Average | | | | Number of | | Grant Date | | | | Shares | | Fair Value | | Outstanding, January 1, 2026 | | 9,351 | | $ | 780.48 | | Granted | | — | | | — | | Vested | | (1,639) | | | — | | Forfeited | | — | | | — | | Outstanding, June 30, 2026 | | 7,712 | | $ | 780.48 | |
|
| AEON Biopharma Inc 2023 Incentive Award Plan |
|
| Share-based Compensation |
|
| Schedule of stock option activity |
| | | | | | | | | | | Weighted | | | | | | Average | | | | Number of | | Exercise | | | | Shares | | Price | | | | | | | | | Outstanding, January 1, 2026 | | 51,016 | | $ | 242.14 | | Options granted | | — | | | — | | Options forfeited | | — | | | — | | Outstanding, June 30, 2026 | | 51,016 | | $ | 242.14 | | Exercisable, June 30, 2026 | | 45,160 | | $ | 169.94 | |
|
| Summary of restricted stock units activity |
| | | | | | | | | | Weighted | | | | | Average | | | Number of | | Grant Date | | | Shares | | Fair Value | | | | | | | Outstanding, January 1, 2026 | | 14,215 | | $ | 60.05 | Granted | | 12,041,479 | | | 0.92 | Vested | | (2,278,801) | | | — | Forfeited | | — | | | — | Outstanding, June 30, 2026 | | 9,776,893 | | $ | 0.94 |
|
| 2025 Employment Inducement Incentive Award Plan |
|
| Share-based Compensation |
|
| Schedule of stock option activity |
| | | | | | | | | | Weighted | | | | | Average | | | Number of | | Exercise | | | Shares | | Price | | | | | | | Outstanding, January 1, 2026 | | 59,034 | | $ | 0.41 | Options granted | | — | | | — | Options forfeited | | — | | | — | Outstanding, June 30, 2026 | | 59,034 | | | 0.41 | Exercisable, June 30, 2026 | | 14,758 | | $ | 0.41 |
|
| Summary of restricted stock units activity |
| | | | | | | | | | Weighted | | | | | Average | | | Number of | | Grant Date | | | Shares | | Fair Value | | | | | | | Outstanding, January 1, 2026 | | 672,141 | | $ | 0.65 | Granted | | 990,566 | | | 0.89 | Vested | | (69,995) | | | — | Forfeited | | — | | | — | Outstanding, June 30, 2026 | | 1,592,712 | | $ | 0.78 |
|